Clinically Negligible Pharmacokinetic and Pharmacodynamic Interactions Between Lanabecestat and Dabigatran Etexilate, a Prototypical P-gp Substrate.
Saved in:
| Title: | Clinically Negligible Pharmacokinetic and Pharmacodynamic Interactions Between Lanabecestat and Dabigatran Etexilate, a Prototypical P-gp Substrate. |
|---|---|
| Authors: | Monk SA; Eli Lilly and Company, Indianapolis, Indiana., Kugler AR; AstraZeneca, Waltham, Massachusetts., Andersen SW; Eli Lilly and Company, Indianapolis, Indiana., Ayan-Oshodi MA; Eli Lilly and Company, Indianapolis, Indiana., James DE; Eli Lilly and Company, Indianapolis, Indiana., Mullen J; AstraZeneca, Waltham, Massachusetts., Zimmer JA; Eli Lilly and Company, Indianapolis, Indiana., Willis BA; Eli Lilly and Company, Indianapolis, Indiana. |
| Source: | Journal of clinical pharmacology [J Clin Pharmacol] 2020 May; Vol. 60 (5), pp. 586-594. Date of Electronic Publication: 2019 Dec 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31853995 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinically Negligible Pharmacokinetic and Pharmacodynamic Interactions Between Lanabecestat and Dabigatran Etexilate, a Prototypical P-gp Substrate. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Monk+SA%22">Monk SA</searchLink>; Eli Lilly and Company, Indianapolis, Indiana.<br /><searchLink fieldCode="AU" term="%22Kugler+AR%22">Kugler AR</searchLink>; AstraZeneca, Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Andersen+SW%22">Andersen SW</searchLink>; Eli Lilly and Company, Indianapolis, Indiana.<br /><searchLink fieldCode="AU" term="%22Ayan-Oshodi+MA%22">Ayan-Oshodi MA</searchLink>; Eli Lilly and Company, Indianapolis, Indiana.<br /><searchLink fieldCode="AU" term="%22James+DE%22">James DE</searchLink>; Eli Lilly and Company, Indianapolis, Indiana.<br /><searchLink fieldCode="AU" term="%22Mullen+J%22">Mullen J</searchLink>; AstraZeneca, Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Zimmer+JA%22">Zimmer JA</searchLink>; Eli Lilly and Company, Indianapolis, Indiana.<br /><searchLink fieldCode="AU" term="%22Willis+BA%22">Willis BA</searchLink>; Eli Lilly and Company, Indianapolis, Indiana. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220366372%22">Journal of clinical pharmacology</searchLink> [J Clin Pharmacol] 2020 May; Vol. 60 (5), pp. 586-594. <i>Date of Electronic Publication: </i>2019 Dec 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0366372 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1552-4604 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200912700%22">00912700 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Pharmacol <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31853995 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/jcph.1558 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 586 Titles: – TitleFull: Clinically Negligible Pharmacokinetic and Pharmacodynamic Interactions Between Lanabecestat and Dabigatran Etexilate, a Prototypical P-gp Substrate. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Monk SA – PersonEntity: Name: NameFull: Kugler AR – PersonEntity: Name: NameFull: Andersen SW – PersonEntity: Name: NameFull: Ayan-Oshodi MA – PersonEntity: Name: NameFull: James DE – PersonEntity: Name: NameFull: Mullen J – PersonEntity: Name: NameFull: Zimmer JA – PersonEntity: Name: NameFull: Willis BA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2020 May Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1552-4604 Numbering: – Type: volume Value: 60 – Type: issue Value: 5 Titles: – TitleFull: Journal of clinical pharmacology Type: main |
| ResultId | 1 |